S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ORGS Orgenesis Inc

0.543

0.0174 (3.31%)

After Hours

Last Updated: 06:39:00

Delayed by 15 minutes

Orgenesis posts four-fold revenue growth in Q1, shares rise 11%

To read the full story on Seeking Alpha, click here.

Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Orgenesis Charts.

Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Orgenesis Charts.

Orgenesis Inc News

Orgenesis Provides Year End Business Update
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
Monday 18 March 2024 (1 month ago) • GlobeNewswire Inc.

Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Orgenesis Inc. Announces $2.3 Million Private Placement
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic
Thursday 1 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 23 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 9 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 9 January 2024 (4 months ago) • Edgar (US Regulatory)

More Orgenesis Inc News Articles

S&P ASX 300 Metals and M...

AUD vs US Dollar

Gold vs US Dollar

Australia And New Zealan...

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions